PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26226N0312VA greater LOS angeles lenalidomide DO — Exelan Pharmaceuticals Inc

Exelan Pharmaceuticals Inc holds $184.3M across 125 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C26226A0006. Recompete timing centers on the Jan 14, 2027 PoP end — agencies typically plan 12–18 months ahead.

262-Network Contract Office 22 (36C262)
Awarding office
Exelan Pharmaceuticals Inc
Recipient
Jan 14, 2027
PoP end
$3.5M
Obligated
$3.5M
Potential
325412
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Exelan Pharmaceuticals Inc — $90

Contract facts

Federal
Contract number36C26226N0312
Also listed as36C262-26-N-0312
Also listed as36C26226A0006-36C26226N0312
Agency262-Network Contract Office 22 (36C262)
Awarding office262-Network Contract Office 22 (36C262)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentExelan Pharmaceuticals Inc
CAGE6GFC4
UEIFYZXNHSQTMG8
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36C26226A0006
Place of performanceBOCA RATON FL
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startJan 15, 2026
PoP end (current)Jan 14, 2027
Obligated$3.5M
Current value$3.5M
Potential value$3.5M

VA GREATER LOS ANGELES LENALIDOMIDE DO is a federal award for 262-Network Contract Office 22 (36C262) held by Exelan Pharmaceuticals Inc. Estimated value $3.5M ($3.5M obligated). Current period of performance ends Jan 14, 2027. Place of performance: BOCA RATON FL.

Recompete timing

Public
Expiring in 146 days

Current PoP ends Jan 14, 2027 (146 days remaining). Agencies typically plan 12–18 months ahead — at 4.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Exelan Pharmaceuticals Inc$184.3M obligated across 125 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($184.3M) · all agencies
Department of Veterans Affairs (VA)$110.2M · 60%Department of Health and Human Services (HHS)$74.1M · 40%Department of Justice (DOJ)$39K · 0%
Open full company profile

Related awards

Same parent · incumbent
36C24826N0088
LENALIDOMIDE
$3.8M
Sep 30, 2026
36C26326F0016
LENOLIDOMIDE CAPSULES
$3.6M
Sep 30, 2026
36C26126N0175
VA PALO ALTO LENALIDOMIDE ORAL CAPSULES
$3.0M
Sep 30, 2026
36C26026F0069
PHARM - LENALIDOMIDE
$1.3M
Sep 30, 2026
36C26326F0019
LENALIDOMIDE CAPSULES
$1.2M
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26226N0312?

36C26226N0312 (VA greater LOS angeles lenalidomide DO) is a 262-Network Contract Office 22 (36C262) award with a potential value of $3.5M, currently held by Exelan Pharmaceuticals Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C262-26-N-0312?

36C262-26-N-0312 is the dashed form of PIID 36C26226N0312 (VA greater LOS angeles lenalidomide DO), held by Exelan Pharmaceuticals Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26226N0312?

262-Network Contract Office 22 (36C262) awarded 36C26226N0312 to Exelan Pharmaceuticals Inc (potential $3.5M).

Who is the incumbent on 36C26226N0312?

Exelan Pharmaceuticals Inc is the incumbent with $184.3M across 125 related awards in SCOUT’s public footprint. The current period of performance ends Jan 14, 2027.

When does Exelan Pharmaceuticals Inc’s 36C26226N0312 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26226N0312